Publication | Open Access
Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance
72
Citations
29
References
2020
Year
MedicinePharmacologyBrigatinib DegraderAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchPotential Treatment
| Year | Citations | |
|---|---|---|
Page 1
Page 1